We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Peter Rehse joins BioFocus as Senior Director, Structural Biology
News

Peter Rehse joins BioFocus as Senior Director, Structural Biology

Peter Rehse joins BioFocus as Senior Director, Structural Biology
News

Peter Rehse joins BioFocus as Senior Director, Structural Biology

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Peter Rehse joins BioFocus as Senior Director, Structural Biology"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

His responsibilities will include managing the structural biology and fragment-based screening groups within the Biological Sciences division.

Peter joins BioFocus from the Chinese CRO Shanghai Medicilon Inc., where, as Vice President, he was responsible for the strategic business and scientific development of the structural biology and structure-based drug design unit.  Prior to this Peter worked at RIKEN Harima Institute, in Japan and has held several academic positions in Japan and Canada.  Peter studied for his PhD under the supervision of Professor Tom Blundell at the University of London and undertook post-doctoral research at the Max-Planck Institute.

“With Peter’s international credibility we will be able to strengthen and grow our structural biology and fragment screening operation,” commented Dr. Kate Hilyard, VP Biological Sciences, BioFocus. “This hire reflects our ongoing commitment to accelerate our client’s discovery programs through investing in the right people."

Advertisement